CLMT Financial Facts
Net loss available to limited partners: -32.7MTotal other expense: -50.9M
See Full Income Statement
Goodwill: 178.6M
Total liabilities and partners' capital: 2.84B
See Full Balance Sheet
Calumet Specialty Products (CLMT) Earnings
|
Expand Research on CLMT
| Next EPS Date | 8/7/26 | EPS Growth Rate | +105.9% |
|---|---|---|---|
| Average EPS % Beat Rate | -168.4% | Revenue Growth Rate | +1.0% |
| Average % Move 1-Wk after EPS | -5.8% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/7/26  |
Q226 | N/A | $0.10 | N/A | N/A | $1.04B | N/A | N/A | N/A | ||
| 5/8/26 | Q126 | -$3.64 | -$0.31 | -$3.33 | $1.03B | $1.01B | N/A |  | | Details | |
| 2/27/26 | Q425 | -$0.43 | -$0.22 | -$0.21 | $1.04B | $1.02B | N/A | | | Details | |
| 11/7/25 | Q325 | $3.61 | -$0.38 | +$3.99 | $1.08B | $1.06B | N/A | | | Details | |
| 8/8/25 | Q225 | -$1.70 | -$0.26 | -$1.44 | $1.03B | $916.73M | N/A | | | Details | |
| 5/9/25 | Q125 | -$1.87 | -$0.38 | -$1.49 | $993.9M | $919.33M | N/A | | | Details | |
| 2/28/25 | Q424 | -$0.47 | -$0.21 | -$0.26 | $949.5M | $1.01B | N/A | | | Details | |
| 11/7/24 |
Q324 | N/A | -$0.13 | N/A | N/A | $1B | N/A | N/A | N/A |
